Blog

Akihiro Ohba: Trastuzumab Deruxtecan in HER 2–Expressing Biliary Tract Cancer

Photo from Akihiro Ohba/X

Aug 12, 2024, 04:06

Akihiro Ohba: Trastuzumab Deruxtecan in HER 2–Expressing Biliary Tract Cancer

Akihiro Ohba, Medical Oncologist at Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, posted on X about recent paper by him as first author, titled “Trastuzumab Deruxtecan in HER2–Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial” published on Journal of Clinical Oncology.

Authors: Akihiro Ohba, Chigusa Morizane, Yasuyuki Kawamoto, Yoshito Komatsu, Makoto Ueno, Satoshi Kobayashi, Masafumi Ikeda, Takuji Okusaka.

“Trastuzumab Deruxtecan in HER 2–Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial | Journal of Clinical Oncology.”

Source: Akihiro Ohba/X

Akihiro Ohba Biliary tract cancer cancer Chigusa Morizane Journal of Clinical Oncology Makoto Ueno Masafumi Ikeda National Cancer Center Hospital OncoDaily Oncology Pancreatic Oncology Satoshi Kobayashi Takuji Okusaka Tokyo trastuzumab Yasuyuki Kawamoto Yoshito Komatsu

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Bernard Fox received SITC lifetime achievement award

Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Special Coverage